Pharmacotherapy 16 (1996): 66-7435. Lancet 336 (1990): 1137-823. N Engl J Med 309 (1983): 816-2146. Clin Pediatr (Phila) 31 (1992): 566-943. McLeod BC "Myocardial infarction in a blood donor after administration of desmopressin." Psychiatric side effects have included a single case of paranoid psychosis associated with the use of DDAVP nasal spray.1. Lancet 345 (1995): 1302-315. Bond L, Bevan D "Myocardial infarction in a patient with hemophilia treated with DDAVP."
"Product Information. Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjorin E "Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease." Other nervous system side effects have included headache and dizziness in less than 3% of patients. Am J Clin Pathol 93 (1990): 522-544. Mannucci PM, Carlsson S, Harris AS "Desmopressin, surgery and thrombosis." Sukhai RN "Enuresis nocturna: long term use and safety aspects of minrin (desmopressin) spray." Lancet 346 (1995): 44710. Current treatment recommendations." Applies to desmopressin: sublingual tablet Other dosage forms: 1. oral tablet 2. injection solution 3. nasal solution, nasal spray
Apnea and Gastrointestinal side effects have included mild abdominal cramps and nausea in 2% of patients. Anesthesiology 88 (1998): 1115-716. Br J Urol 72 (1993): 42-525. Thrombocytopenia after desmopressin but absence of in vitro hypersensitivity to ristocetin." J Pediatr 114 (1989): 711-824. Pharmacotherapy 16 (1996): 66-7435. BMJ 306 (1993): 116933. Hourihane J, Salisbury AJ "Use caution in prescribing desmopressin for nocturnal enuresis." Yaouyanc G, Jonville AP, Yaouyanc-Lapalle H, Barbier P, Dutertre JP, Autret E "Seizure with hyponatremia in a child prescribed desmopressin for nocturnal enuresis." Hartmann S, Reinhart W "Fatal complication of desmopressin." Pediatrics 94 (1994): 841-641. Mannucci PM, Lusher JM "Desmopressin and thrombosis." Asplund R, Aberg H "Desmopressin in elderly women with increased nocturnal diuresis.
Eur J Pediatr 155 (1996): 959-6240. Sweeney JD, Hoernig LA, Behrens AN, Novak E, Swank RT "von Willebrand's variant (type II Buffalo). DDAVP nasal spray has been infrequently associated with somnolence, The risk factors for DDAVP-induced hyponatremia include Hematologic side effects have included platelet aggregation and Local side effects of injections of DDAVP have included intravenous site Respiratory side effects of intranasal DDAVP have included rhinitis, epistaxis, and nostril pain in 2% to 10% of patients. You may report side effects to FDA at 1-800-FDA-1088. Byrnes JJ, Larcada A, Moake JL "Thrombosis following desmopressin for uremic bleeding."
Thrombocytopenia after desmopressin but absence of in vitro hypersensitivity to ristocetin." Robson WLM "Water intoxication in patients treated with desmopressin." Beach PS, Beach RE, Smith LR "Hyponatremic seizures in a child treated with desmopressin to control enuresis. Sweeney JD, Hoernig LA, Behrens AN, Novak E, Swank RT "von Willebrand's variant (type II Buffalo). Albert SG, Salvato-Lechner V, Joist JH "Venous thromboembolism and transient thrombocytopenia in a patient with diabetes insipidus treated with desmopressin acetate (DDAVP)." Hartmann S "Fatal complication of desmopressin - reply." Weinstein RE, Bona RD, Altman AJ, Quinn JJ, Weisman SJ, Bartolomeo A, Rickles FR "Severe hyponatremia after repeated intravenous administration of desmopressin." Williford SL "Water intoxication in patients treated with desmopressin - reply." Am J Hematol 44 (1993): 12-536. 18. There have been rare reports of thrombotic events (acute cerebral thrombosis, acute myocardial infarction) in some patients after DDAVP injection. Israels SJ, Kobrinsky NL "Serious reaction to desmopressin in a child with cyanotic heart disease." Hjalmas K, Bengtsson B "Efficacy, safety, and dosing of desmopressin for nocturnal enuresis in Europe." Lancet 346 (1995): 44710. Br J Clin Pharmacol 17 (1984): 369-712. Forest Pharmaceuticals, St. Louis, MO. Apnea and Gastrointestinal side effects have included mild abdominal cramps and nausea in 2% of patients. Castaman G, Rodeghiero F, Lattuada A, Mannucci PM "Desmopressin-induced thrombocytopenia in type I platelet discordant von Willebrand disease." Pharmacotherapy 16 (1996): 969-7037.
Odeh M, Oliven A "Coma and seizures due to severe hyponatremia and water intoxication in an adult with intranasal desmopressin therapy for nocturnal enuresis."
Lancet 2 (1989): 675-614. Am J Hematol 31 (1989): 199-20231.
DDAVP (desmopressin)." Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjorin E "Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease." J Toxicol Clin Toxicol 30 (1992): 637-4132.